Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients’ Survival: Single Center Experience and Literature Review

SIMPLE SUMMARY: The widespread use of immune checkpoint inhibitors (ICI) came along with a new challenge for oncologists, immune-related adverse events (irAE). A positive correlation between irAE onset and ICI efficacy has been suggested. However, it remains unsettled. Whether the association exists...

Descripción completa

Detalles Bibliográficos
Autores principales: Romão, Raquel, Mendes, Ana S., Ranchor, Ridhi, Ramos, Maria João, Coelho, João, Pichel, Rita Carrilho, Azevedo, Sérgio Xavier, Fidalgo, Paula, Araújo, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913676/
https://www.ncbi.nlm.nih.gov/pubmed/36765845
http://dx.doi.org/10.3390/cancers15030888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913676/
https://www.ncbi.nlm.nih.gov/pubmed/36765845
http://dx.doi.org/10.3390/cancers15030888

Ejemplares similares